# Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra

> **NCT05172167** · — · UNKNOWN · sponsor: **Universidad de Antioquia** · enrollment: 200 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Levels of IgG and IgM SARS-CoV-2 antibodies blood test.
- **DIAGNOSTIC_TEST:** RT-PCR SARS-CoV-2 nasopharyngeal swab

## Key facts

- **NCT ID:** NCT05172167
- **Lead sponsor:** Universidad de Antioquia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-02
- **Primary completion:** 2022-04-15
- **Final completion:** 2022-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05172167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05172167, "Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05172167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*